Tuesday, October 15, 2019

Multigene testing for all patients with breast cancer cost-effective, ‘will save more lives


Multigene testing for all patients with breast cancer could be a cost-effective way to reduce disease burden compared with testing based upon family history or other clinical criteria, according to study results.
“Our research strategy is focused on targeted precision prevention, [and] a key theme in our research strategy for a long time has been broadening access to genetic testing. This will increase the number of people who can access prevention and screening and reduce burden of disease well beyond what is possible through current clinical protocols,” Ranjit Manchanda, MD, PhD, clinical senior lecturer at Wolfson Institute of Preventive Medicine of Barts Cancer Institute at Queen Mary University of London, told HemOnc Today. “This has two components and approaches — increasing testing at cancer diagnosis and population testing. The work for this particular paper is providing evidence for testing all [patients with] breast cancer.”

Source-  https://bit.ly/2VSekgN

Contact us on –
 
More details on- https://breastcancer.pulsusconference.com/
 
breastcancer Congress Spain abstract Research Group

Tuesday, October 1, 2019

Breast Cancer 2020 | Spain



In recent years,Researcher have seen remarkable progress in treatment options and improved outcomes for breast cancer patients. 

To know more join us @Barcelona, Spain April 29-30,2020 

More Details- https://bit.ly/2s8xD6O
 
BreastCancerCongress CancerSurvivor Research Spain #Speaker #Conference


Tuesday, August 6, 2019

Radiation Therapy | Breast Cancer 2019

Microbubbles make breast cancer more susceptible to radiation therapy


Bursting oxygen-filled microbubbles in breast cancer makes tumours three times more sensitive to radiation therapy in preliminary tests with animal models of the disease…

Injecting breast cancer with oxygen-filled microbubbles makes tumours three-times more sensitive to radiation therapy and improves survival in animal models of the disease. The study makes a strong case for moving this technology into clinical trials with breast cancer patients. 


More details about congress-   https://bit.ly/2s8xD6O

keynote conference research speaker Scotland cancer September oncology


 

Sunday, July 14, 2019

Scotland trip with Breast Cancer Congress

It’s a glad welcome to all Professors, Business delegates, young Researchers, and scholars to have a look at our organization. Today is the day you begin to learn to look through the eyes of others; to find out and experience what the world is like for you. Here we provide a tremendous opportunity to join in this forum to utilize the expertise and novelties that expands your views in the fields of Research, collaboration, networking opportunity.

More info- https://bit.ly/2s8xD6O
 
keynote conference research speaker Scotland cancer September oncology

Multigene testing for all patients with breast cancer cost-effective, ‘will save more lives

Multigene testing for all patients with breast cancer could be a cost-effective way to reduce disease burden compared with testin...